These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15258776)

  • 61. Low-fluence-rate photodynamic therapy to treat subfoveal choroidal neovascularization in pathological myopia. A study of efficacy and safety.
    Besozzi G; Sborgia L; Furino C; Cardascia N; Dammacco R; Sborgia G; Modoni AP; Boscia F
    Graefes Arch Clin Exp Ophthalmol; 2010 Apr; 248(4):497-502. PubMed ID: 19916015
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia.
    Gibson J
    Eye (Lond); 2005 Aug; 19(8):829-30. PubMed ID: 16086038
    [No Abstract]   [Full Text] [Related]  

  • 63. Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes.
    Ruiz-Moreno JM; Montero JA
    Br J Ophthalmol; 2003 Jul; 87(7):856-9. PubMed ID: 12812885
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization.
    Gelisken F; Inhoffen W; Karim-Zoda K; Grisanti S; Partsch M; Voelker M; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2005 Mar; 243(3):198-203. PubMed ID: 15258778
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease.
    Lim JI; Flaxel CJ; LaBree L
    Ann Acad Med Singap; 2006 Mar; 35(3):198-202. PubMed ID: 16625270
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Photodynamic therapy for age-related macular degeneration.
    Jin C; Ge J; Zhou S; Chen H; Zhong X; Jiang R; Chen L; Chen L
    Yan Ke Xue Bao; 2004 Sep; 20(3):158-62. PubMed ID: 15499723
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Retinal pigment epithelium changes after photodynamic therapy for choroidal neovascularization in pathological myopia.
    Parodi MB; Da Pozzo S; Ravalico G
    Acta Ophthalmol Scand; 2007 Feb; 85(1):50-4. PubMed ID: 17244210
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation.
    Harding S
    Eye (Lond); 2001 Jun; 15(Pt 3):407-12. PubMed ID: 11450766
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.
    Montero JA; Ruiz-Moreno JM
    Br J Ophthalmol; 2003 Feb; 87(2):173-6. PubMed ID: 12543746
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization.
    Lanzetta P; Parodi MB; Ambesi-Impiombato M; Ravalico G; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):840-4. PubMed ID: 15221306
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks.
    Arias L; Pujol O; Rubio M; Caminal J
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):753-7. PubMed ID: 16228218
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy.
    Menchini U; Virgili G; Introini U; Bandello F; Ambesi-Impiombato M; Pece A; Parodi MB; Giacomelli G; Capobianco B; Varano M; Brancato R
    Retina; 2004 Oct; 24(5):763-71. PubMed ID: 15492632
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Photodynamic therapy for choroidal neovascularisation secondary to basal laminar drusen.
    Guigui B; Martinet V; Leveziel N; Coscas G; Soubrane G; Souied EH
    Eye (Lond); 2009 Nov; 23(11):2115-8. PubMed ID: 19798112
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Photodynamic therapy with verteporfin in treatment of myopic neovascular choroideal membranes].
    Vysloužilová D; Kolář P; Matušková V
    Cesk Slov Oftalmol; 2012 Oct; 68(4):131-4. PubMed ID: 23214483
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Variable outcome of photodynamic therapy for choroidal neovascularization associated with choroidal nevus.
    Parodi MB; Boscia F; Piermarocchi S; Ferrari TM; Furino C; Sborgia C
    Retina; 2005 Jun; 25(4):438-42. PubMed ID: 15933589
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.
    Chan WM; Lam DS; Wong TH; Lai TY; Kwok AK; Tam BS; Li KK
    Ophthalmology; 2003 Dec; 110(12):2395-402. PubMed ID: 14644724
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Photodynamic therapy for juxtafoveal choroidal neovascularization associated with multifocal choroiditis.
    Parodi MB; Iacono P; Spasse S; Ravalico G
    Am J Ophthalmol; 2006 Jan; 141(1):123-8. PubMed ID: 16386985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
    Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A
    Retina; 2006; 26(9):988-93. PubMed ID: 17151484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.